Menu
GeneBe

rs146125558

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4BS1_Supporting

The NM_001159702.3(FHL1):c.5C>T(p.Ala2Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000024 in 1,210,710 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A2A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000044 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 0.000022 ( 0 hom. 8 hem. )

Consequence

FHL1
NM_001159702.3 missense

Scores

2
2
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 7.90
Variant links:
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.33708543).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0000445 (5/112482) while in subpopulation NFE AF= 0.0000939 (5/53225). AF 95% confidence interval is 0.0000369. There are 0 homozygotes in gnomad4. There are 0 alleles in male gnomad4 subpopulation. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FHL1NM_001159702.3 linkuse as main transcriptc.5C>T p.Ala2Val missense_variant 3/8 ENST00000394155.8
FHL1NM_001159699.2 linkuse as main transcriptc.53C>T p.Ala18Val missense_variant 2/6 ENST00000370683.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FHL1ENST00000394155.8 linkuse as main transcriptc.5C>T p.Ala2Val missense_variant 3/85 NM_001159702.3 Q13642-2
FHL1ENST00000370683.6 linkuse as main transcriptc.53C>T p.Ala18Val missense_variant 2/61 NM_001159699.2 P1Q13642-5

Frequencies

GnomAD3 genomes
AF:
0.0000445
AC:
5
AN:
112482
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
34640
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000939
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000327
AC:
6
AN:
183451
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
67887
show subpopulations
Gnomad AFR exome
AF:
0.0000760
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000625
Gnomad NFE exome
AF:
0.0000366
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000219
AC:
24
AN:
1098228
Hom.:
0
Cov.:
31
AF XY:
0.0000220
AC XY:
8
AN XY:
363582
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000284
Gnomad4 ASJ exome
AF:
0.0000516
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000493
Gnomad4 NFE exome
AF:
0.0000237
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000445
AC:
5
AN:
112482
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
34640
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000939
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000831
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 04, 2021Has not been previously published as pathogenic or benign to our knowledge -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 02, 2018- -
X-linked myopathy with postural muscle atrophy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 2 of the FHL1 protein (p.Ala2Val). This variant is present in population databases (rs146125558, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with FHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 289087). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 02, 2021The p.A2V variant (also known as c.5C>T), located in coding exon 1 of the FHL1 gene, results from a C to T substitution at nucleotide position 5. The alanine at codon 2 is replaced by valine, an amino acid with similar properties. Based on data from gnomAD, the T allele has an overall frequency of <0.01% (6/183451) total alleles studied, with 0 hemizygote(s) observed. The highest observed frequency was <0.01% (1/13161) of African alleles. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.43
Cadd
Uncertain
23
Dann
Uncertain
1.0
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Pathogenic
0.44
D
MetaRNN
Benign
0.34
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.55
T
MutationAssessor
Benign
1.9
L;L;L;.;L;.;.;.;.;L;.;.;.;L;.;.;L;L;.;.;.;L;.;.;.;.;.;L
MutationTaster
Benign
0.90
D;D;D;D;D;D;D;D;D
PrimateAI
Benign
0.47
T
Sift4G
Uncertain
0.0080
D;D;D;D;D;D;D;D;D;D;D;D;.;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
0.82, 0.37
.;P;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;P;.;.;.;B;.;.
Vest4
0.14
MVP
0.73
MPC
0.50
ClinPred
0.30
T
GERP RS
5.7
Varity_R
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs146125558; hg19: chrX-135288596; COSMIC: COSV61779475; COSMIC: COSV61779475; API